Identification of chondroitin polymerizing factor as a biomarker for predicting immunotherapy response in breast cancer: a bioinformatics analysis of tumor microenvironment
{{output}}
Background: Immune checkpoint blockade (ICB) therapy offers remarkable clinical advantages for various cancers, but many patients still fail to receive sustained benefits from this treatment. Tumor microenvironment (TME), a multi... ...
